|
|
|||
| |||||||||||||||||||||||||||||||||||||
The Obama administration and others have emphasized the cost-saving potential of prevention, comparative-effectiveness research, disease management, and health information technology. But there is little evidence that these worthwhile measures would produce meaningful cost control over the next decade.1 The Congressional Budget Office (CBO) has consequently forecast scant savings from these sources, fueling debate about
Source Information
From the University of North Carolina, Chapel Hill (J.O.); and Case Western Reserve University, Cleveland (J.W.).
This article (10.1056/NEJMp0907487) was published on September 2, 2009, at NEJM.org.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2010 Massachusetts Medical Society. All rights reserved. |